Home
Technology
Drug Delivery Platform
Sensitive DNA/RNA Synthesis Platform
Products & Services
COVID-19 Research Support
Liposomes Drug Delivery Services For COVID-19
COVID-19 mRNA Vaccine Development Services
Custom Oligo Synthesis Services For COVID-19 Research
DNA/RNA Synthesis Reagents
Common RNA Synthesis
Sensitive DNA/RNA Synthesis
Dyes Phosphoramidites
Labels Phosphoramidites
Oligo Analysis & Purification
siRNA
Custom siRNA
Chemically-Modified siRNA
Fluorescence-labeled siRNA
siRNA Control
siRNA Sets
Drug Delivery System
Exosome
Liposomes
GalNAc-siRNA Conjugates
Antibody-siRNA Conjugates
Peptide-siRNA conjugates
Polymer-siRNA Conjugates
Cholesterol-siRNA Conjugates
Nanoparticle-siRNA Conjugates
mRNA Vaccines
Support
News
mRNA-1647，the first infectious disease mRNA vaccine to enter the second phase of research
Onpattro, The First FDA-approved RNAi Drug
FDA approves first RNAi treatment for inherited rare diseases
Resources
Explore & Learn
FAQs
FAQs of siRNA
Ordering
About Us
Contact Us
Home
Support
Support
Support
News
Resources
FAQs
*
Only for research. Not suitable for any diagnostic or therapeutic use.
CONTACT US
Call us at:
International: 1-631-504-6093
Europe: 44-203-286-1088
US & Canada (Toll free):
1-844-BOC(262)-0123
Email:
Fax: 1-631-614-7828
45-16 Ramsey Road, Shirley, NY 11967, USA
